Objectives: The Gram-negative human pathogen Klebsiella oxytoca is often resistant to several antibiotics such as fluoroquinolones, erythromycin, tetracycline, chloramphenicol and others. The aim of this study was to look at the mechanisms leading to this resistance and particularly the role of TolC and efflux mechanisms in determining resistance.
Introduction
Klebsiella is an opportunistic pathogen leading to severe diseases, and it can also contaminate food, enteral feedings and infusion fluids, leading to common-source outbreaks.
1 Klebsiella oxytoca carries a constitutive b-lactamase that confers low-level resistance to penicillins but no significant resistance to other b-lactams. 2 Yigit et al. 3 provided evidence that a K. oxytoca strain carried a gene encoding a carbapenemase on a mobile element. Klebsiella synthesizes two major porins, OmpK35 and OmpK36 (homologues of OmpF and OmpC), and a quiescent porin, OmpK37. 4 Efflux causes decreases in the intracellular concentrations of drugs that can eventually lead to subtoxic levels, thus inducing phenotypic resistance. 5 In Enterobacteriaceae, the major multidrug transporter is AcrB, which belongs to the resistance-nodulation-cell division (RND) superfamily. 6 The RND efflux pumps usually need two other proteins to be functional, i.e. to facilitate the efflux of noxious compounds directly to the external medium. 7 In Escherichia coli, this efflux machinery is formed by an inner membrane transporter, AcrB, a periplasmic membrane fusion protein, AcrA, and an outer membrane channel protein, TolC. 8, 9 TolC plays a key role in the import of antibacterial proteins such as colicin E1 and participates in other secretion mechanisms, such as secretion of a-haemolysin, and in the regulation of porin levels. 10 -12 TolC, but not AcrB, mediates the uptake of multidrug-resistant Salmonella enterica serovar Typhimurium into target intestinal cells; it is also known for its role in bile salt resistance, reinforcing the interest in targeting research towards TolC for fighting multidrug-resistant Gramnegative bacteria.
Multiresistant strains of Klebsiella have emerged since 1980, particularly strains producing extended-spectrum b-lactamases. 14, 15 Alternative antibiotic compounds (such as quinolones) have therefore become necessary. Resistance to quinolones (by alteration in the GyrA subunit of DNA gyrase and/or in the ParC subunit of DNA topoisomerase IV) in the hospital setting has been reported and is a matter of concern. 16 An additional mechanism involving active efflux has been found in E. coli strains with high levels of resistance and is associated with both multiple mutations in the topoisomerase genes and overexpression of the AcrAB multidrug efflux system. 17 Disruption of genes encoding multidrug efflux pumps resulted in a remarkable decrease in resistance to multiple antimicrobial agents. 18 Two multidrug efflux pumps have been reported in K. pneumoniae, AcrAB and QacE; recently, a new efflux pump (KmrA) has been identified. 19 In this work, we explore some of the mechanisms leading to resistance in K. oxytoca as well as characterize the outer membrane protein TolC as a member of the efflux pumps.
Materials and methods
Bacterial strains and plasmids, media and growth conditions K. oxytoca HUB 179213 was isolated from the urine of a 75-yearold man affected by a urinary tract infection at the Hospital Universitari de Bellvitge (University of Barcelona). Identification as well as preliminary antibiotic susceptibility testing were accomplished using the Microscan system (Sacramento, CA, USA). Strain C600tolC,Tn5, having a kanamycin cassette inserted into its tolC gene, derived from E. coli C600, was used in cloning experiments (a gift from Elisabeth Pradel). Plasmid pUC18TolC was obtained from pUC18 and carries the tolC gene of K. oxytoca.
For experiments reported here, bacteria were cultured in Luria -Bertani (LB) broth and agar, Trypticase soy broth (TSB) or Trypticase soy agar (TSA) depending on the experiment. Bacteriological media were purchased in dehydrated form from Scharlau (Barcelona, Spain).
Drug susceptibility testing
The MICs of antimicrobial agents were determined by microdilution in Mueller -Hinton broth, according to the guidelines of the CLSI (formerly NCCLS).
The following antimicrobials were tested: erythromycin, tetracycline, chloramphenicol, nalidixic acid, ciprofloxacin, norfloxacin, novobiocin, ofloxacin, rifampicin, enrofloxacin, gentamicin, imipenem, meropenem, ceftriaxone, cefotaxime, acriflavin and Crystal Violet. MICs were also determined in the presence of a fixed concentration of the efflux pump inhibitor carbonyl cyanide m-chlorophenylhydrazone (CCCP). All antibiotics were purchased from Sigma Chemical Co. (St Louis, MO, USA).
Accumulation of ciprofloxacin
Ciprofloxacin accumulation was measured spectrofluorometrically using the method described by Mortimer and Piddock 20 with some modifications. 21 Isolates were incubated at 378C in TSB until A 600 reached values from 0.5 to 0.7. Bacteria were harvested by centrifugation (9000 g) at room temperature, washed and concentrated 10-fold in PBS, pH 7.5. Bacteria were incubated for 10 min at 378C and ciprofloxacin added to a final concentration of 10 mg/L. After the addition of ciprofloxacin, 1 mL samples were removed at different time intervals. Three minutes after the addition of ciprofloxacin, the efflux pump inhibitor CCCP (final concentration 100 mM) was added when necessary. The samples were immediately diluted in 1 mL of ice-cold PBS and centrifuged for 1 min at 11 000 rpm in a microcentrifuge. Pellets were resuspended in 1 mL of 0.1 M glycine buffer at pH 3.0 and finally incubated at room temperature overnight to allow bacterial lysis. Thereafter, the suspensions were centrifuged at 208C for 15 min to remove bacterial debris. The fluorescence of the supernatant was measured using an SLM Aminco 8100 spectrofluorometer (SLM-Aminco, Urbana, IL, USA).
The growth inhibition assays were performed as described by Beyer et al. 22 with some modifications. K. oxytoca strains were inoculated at 1Â10 6 -2Â10 6 cfu/mL into tubes containing TSB with antibiotics at concentrations one-fourth the previously determined MIC, either in the presence or absence of CCCP (10 mg/L final concentration). Bacteria were incubated at 378C, and optical density values at a wavelength of 550 nm were registered over $8 h. The OD 550 values were measured after 7 h, and results plotted.
PCR amplification
Genomic DNA of K. oxytoca was analysed for the existence of loci encoding tolC. Specific primers for the Enterobacter aerogenes tolC gene were designed and used in an attempt to amplify K. oxytoca tolC. PCRs were carried out in 50 mL volumes containing 10 mL of 10Â PCR buffer (100 mM Tris -HCl pH 9.0, 500 mM KCl, 1.5 mM MgCl 2 and 0.2 mM of each dNTP), 25 pmol of each of the TolC forward primer (5 0 -AGCACATCTA GATCACGCACC-3 0 ) and the TolC reverse primer (5 0 -TCGG CGTTCTGATCTAGACAA-3 0 ), 1 U of Taq DNA polymerase (Fermentas Vilnius, Lithuania), 1 mL of K. oxytoca DNA and 24 mL of sterile distilled water. Thermal cycling reaction parameters included an initial denaturation at 948C for 5 min, followed by 25 cycles of 948C for 1 min, 518C for 1 min and 4 min of extension at 728C, and a final extension at 728C for 10 min. All completed reactions were maintained at 48C. The PCR products were visualized using 0.7% agarose gel electrophoresis (85 V for 2 h); gels were stained with ethidium bromide.
DNA sequence analysis
Any amplified PCR products of interest were purified with the MiniElute PCR Purification Kit (Qiagen, West Sussex, UK) according to the guidelines of the manufacturer. Each gel-purified product was sequenced using BigDye Terminator (version 3.1; Applied Biosystems, Foster City, CA, USA). Sequences were initially compared with the current GenBank sequence databases using the BLAST suite of programs. 23 
Cloning and plasmid construction
Restriction digestion, ligation and E. coli transformation were performed as described by Sambrook et al. 24 The full-length tolC gene of K. oxytoca was digested with the XbaI restriction enzyme, followed by insertion into pUC18 at the XbaI site. The ensuing plasmid, named pUC18TolC, was inserted into E. coli C600tolC,Tn5 resulting in the strain named C600pUC18TolC. For transformation, a single colony of C600tolC,Tn5 was inoculated in 2 mL of LB broth and grown while being shaken overnight at 378C. The culture was diluted 1/50 in 50 mL of LB broth and grown while being shaken at 378C for 6 h. The culture was then centrifuged and washed four times with 20 mL of 10% ice-cold glycerol. The cell pellet was suspended in 9 mL of 10% glycerol and maintained on ice. A volume of 70 mL of the competent bacterial suspension was mixed with 5 mL of plasmid DNA (from 0.1 to 1 mg of DNA) in water, chilled on ice for 5 min and pulsed using a Cell-Porator (Pharmacia LKB . ECPS 3000/150) at 150 mF and 1400 V. Cells were transferred immediately to 1 mL of LB broth and grown while being shaken at 378C for 1 h. The culture was then centrifuged, and the pellet was suspended in 0.1 mL of LB broth. Aliquots of suspended bacteria were spread on LB agar plates containing appropriate antibiotics.
Structure modelling
The structure modelling was performed using Modeller, a program to compare modelling of three-dimensional (3D) protein structures. 25 The user provides an alignment of the sequence to be modelled with known related structures, while Modeller automatically calculates a model containing all non-hydrogen atoms. Modeller implements comparative protein structure modelling by the satisfaction of spatial restraints 26, 27 and performs many additional tasks, including de novo modelling of loops in protein structures, optimization of various models of protein structure with respect to a flexibly defined objective function, multiple alignment of protein sequences and/or structures, clustering, searching of sequence databases, comparison of protein structures, etc. Once the target template was constructed, Modeller calculated a 3D model of the target. A script was used to generate the most similar model of TolC based on the template structure, in this case TolC of E. coli. The model was viewed by Pymol, a program that reads the PDB format. 28 Then a loop refinement was done using ModLoop, a web server for automated modelling of loops in protein structures. This server relies on the loop modelling routine in Modeller that predicts the loop conformations by the satisfaction of spatial restraints, without relying on a database of known protein structures. 29 
Colicin susceptibility
Colicin was prepared from colicinogenic bacteria grown in TSB at 378C with aeration to early log phase, induced with 0.4 mg of mitomycin per mL and incubated for 3 h at 378C with aeration. The cells were collected by centrifugation at 10 000 g, and the supernatant, containing colicin E1, E2 and E3, was precipitated with ammonium sulphate. The susceptibility to the three colicins was determined by spotting 2-fold serial dilutions of the colicin stock solution on bacterial lawns. Killing zones were recorded after 6-8 h of incubation at 378C.
TolC purification
TolC protein was expressed and purified as follows. Cultures (1 L) of an E. coli strain harbouring a plasmid containing the tolC gene from K. oxytoca were prepared, and cells were harvested by centrifugation and broken using a French Press. The membranes were collected (50000 g for 1 h) and washed three times in 20 mM HCl -Tris pH 7.4/20 mM MgCl 2 /0.5% Triton X-100 (Merck). TolC was solubilized in 20 mM HCl-Tris pH 7.4/20 mM MgCl 2 /5% Triton X-100/10% glycerol. After resuspension, insoluble material was removed by centrifugation at 50000 g for 20 min. The supernatant was placed on a Q Sepharose anion exchange column (5 mL HiTrap Q Pharmacia) and eluted with an NaCl gradient in 20 mM HCl-Tris pH 7.4/0.5% Triton X-100. TolC was then pure.
Results

Antibiotic susceptibility testing
The results of the antibiotic susceptibility tests (MICs) are reported in Table 1 . MIC values obtained in the presence of the efflux pump inhibitor CCCP were lower than the MIC values obtained without CCCP.
Accumulation of ciprofloxacin
As K. oxytoca 179213 showed high quinolone resistance (Table 1) , the intracellular accumulation of ciprofloxacin was measured in order to identify the existence of an active efflux pump. This was done in the presence and absence of the membrane energy uncoupler CCCP. Since quinolone efflux is energy-dependent, incubation with CCCP indicated the role of an active efflux pump in the intracellular concentration of ciprofloxacin. Figure 1 illustrates the results obtained. A low level of intracellular accumulation of ciprofloxacin was found in the absence of CCCP. In contrast, a noticeable increase in intracellular drug concentration was observed in the presence of the inhibitor. The addition of CCCP enhanced ciprofloxacin's effect on bacterial growth; at concentrations of 0.10 mg/L, growth was almost completely inhibited in the presence of CCCP, whereas growth was unaltered by the fluoroquinolone alone (data not shown). Thus it can be assumed that the activity of the efflux mechanism was significantly inhibited by the addition of the energy uncoupler CCCP.
K. oxytoca tolC cloning and sequencing
Using primers generated from the tolC sequence of E. aerogenes, PCR amplification yielded a 2.1 kb fragment carrying the complete tolC gene of K. oxytoca, which was cloned and sequenced (GenBank DQ838802). E. coli C600tolC,Tn5 expressing tolC was used to determine the sequence. The deduced amino acid sequence of the tolC gene of K. oxytoca HUB 179213 was compared with the sequences of the TolC protein of E. aerogenes, S. enterica and E. coli (Figure 2 ). Nucleotide sequence analysis of the 2127 base PCR fragment indicates that the tolC gene from K. oxytoca encodes an open reading frame of 1457 nt. A putative promoter sequence with 210 (TACCAAT), Pribnow box and 235 (TTGACAT) regions lies 50 nt upstream of the start codon (ATG). The presumed initiator methionine is preceded by a canonical ribosome-binding site (GGAGGA). The deduced amino acid sequence encoded by the 2127 nt sequence of the tolC gene of K. oxytoca HUB 179213 showed a high degree of identity with several TolC proteins: 92% identity with the TolC protein of E. aerogenes, 81% identity with the TolC protein of S. enterica and 79% identity with the TolC protein of E. coli (Figure 2 ). The most apparent difference was localized between amino acids 286 and 293, where K. oxytoca HUB 179213 showed a six amino acid deletion; in addition, there was a three amino acid deletion between amino acids 465 and 469.
K. oxytoca tolC can functionally complement an E. coli tolC mutant
TolC mutants of E. coli are hypersensitive to detergents such as SDS and a variety of hydrophobic agents such as novobiocin. 30 The tolC gene of K. oxytoca inserted into plasmid pUC18 (pUC18TolC) was transformed into an E. coli tolC-deleted strain (C600tolC,Tn5) and transformants were selected on LB agar plates containing SDS and appropriate antibiotics. We examined the resistance to ciprofloxacin due to the efflux pump of this strain, named C600pUC18TolC, by measuring intracellular accumulation of ciprofloxacin in the presence of the membrane energy uncoupler CCCP. The results for strains E. coli C600tolC,Tn5 and C600pUC18TolC are shown in Figure 3 . A low level of intracellular accumulation of ciprofloxacin was found in the presence and absence of CCCP for C600tolC,Tn5. However, an increase in intracellular ciprofloxacin concentration by strain C600pUC18TolC was obtained in the presence of the inhibitor. These results pointed to the actual role of the TolC protein in the efflux of antibiotic out of the cell, and, moreover, that K. oxytoca tolC was able to complement the E. coli tolC mutant to drug resistance.
Structural model of TolC
The closest homology (87%) was seen with 1ek9 (TolC of E. coli). The TolC amino acid sequence was threaded to the 1ek9 crystal structure based on the alignment. The first 24 residues and the last 39 residues of TolC were excluded since there are no corresponding residues in the 1ek9 structure. The alignment already shows that the parts of the sequence that form b-strands in 1ek9 from E. coli are highly conserved. The highest variability was found in regions forming the extracellular loops (Figure 4 ). It has been shown that these regions are responsible for colicin attachment in E. coli (namely ColE1). C-600 was susceptible to colicin E1, whereas the clones E. coli C600tolC,Tn5 and C600pUC18TolC as well as K. oxytoca HUB 179213 were resistant to the three colicins tested (ColE1, ColE2 and ColE3).
Discussion
Species of the genus Klebsiella are naturally resistant to many b-lactams due to their ability to produce b-lactamases (mostly chromosomal SHV);~40% of strains harbour a plasmid encoding SHV-5. 5 The data in Table 1 show that K. oxytoca HUB 179213 is resistant to several commonly used antibiotics and exhibits high resistance to quinolones, reaching MICs .4 mg/L (according to the recommendations of the CLSI, formerly the NCCLS) 31 . The actual role of efflux in determining resistance in K. oxytoca is unknown. When determining MICs of a wide series of antimicrobial agents, MIC values became strongly affected by the efflux pump inhibitor CCCP, except in the case of imipenem, meropenem, ceftriaxone and cefotaxime (Table 1) . Strain HUB 179213 exhibited high-level resistance to fluoroquinolones. It has been shown that quinolone resistance in Enterobacteriaceae is generally caused by a cooperative effect between mutations in the genes gyrA and parC and efflux pumps, mostly acrAB. The measurements of the accumulation of quinolones by this bacterium either with or without the energy uncoupler CCCP suggested that an active efflux mechanism significantly contributes to fluoroquinolone resistance in the isolate K. oxytoca HUB 179213. In addition, sequences of gyrA and parC genes cannot explain the resistance of the strain to quinolones. The inhibition assays demonstrated that the presence of the inhibitor CCCP at sublethal concentrations of ciprofloxacin resulted in complete inhibition of growth. A similar experiment using the strain K. pneumoniae CECT 434, a fully susceptible strain, was unable to detect differences between curves obtained with or without CCCP. The presence of acrAB was tested by PCR amplification by using primers constructed on the basis of acrA and acrB sequences of E. coli. Two amplicons of 1.2 kb (acrA) and 3.15 kb (acrB) were obtained, showing that the resistant strains harbour genes of the efflux machinery.
The outer membrane protein involved in the function of AcrAB has been demonstrated to be the TolC protein in several Enterobacteriaceae. However, up to now, almost nothing has been published concerning the actual role of TolC or the TolC-like protein in the genus Klebsiella. An amplicon of 2.2 kb was obtained by PCR (almost identical in size with that obtained in E. aerogenes) (data not shown). A recombinant plasmid containing tolC was able to complement a tolC mutant of Enterobacter cloacae. The sequence encoded by the tolC from K. oxytoca was obtained and compared with the sequence encoded by tolC of other enterobacteria such as E. aerogenes, E. coli and S. enterica by using BLAST (Figure 2) . The sequence was submitted to GenBank (accession number DQ838802). The most significant differences can be found between amino acids 280 and 290, in which K. oxytoca lacks six amino acids forming part of the loop exposed to the external side of the outer membrane. It was supposed that this region would play some role in the attachment of colicins and bacteriophages. Results of colicin susceptibility revealed that K. oxytoca is resistant to ColE1, which is known to use an external part of TolC as a receptor.
